During metabolic symbiosis, SLC16A1 is involved in the influx of lactic acid into oxidative cancer cells, while SLC16A3 is involved in the efflux of lactate from glycolytic cancer cells (Sonveaux et al., 2008; Payen et al., 2020). Here, SLC16A3 is linked to cancer.